Skip to main content

Advertisement

Figure 5 | Clinical and Translational Allergy

Figure 5

From: Sustained efficacy and safety of a 300IR daily dose of a sublingual solution of birch pollen allergen extract in adults with allergic rhinoconjunctivitis: results of a double-blind, placebo-controlled study

Figure 5

Symptoms and medication scores. Average Rescue Medication Score (A), Average Rhinoconjunctivitis Total Symptom Score (B) and Average Rhinoconjunctivitis Symptom Scores (C) for Periods 1 and 2 in the FASP1 and FASP2. ANCOVA *p < 0.05; **p < 0.001; ***p < 0.0001.

Back to article page